RELX Stock Analysis: Relx | NYSE
Specialty Business Services | NYSE, USA | Market Cap: 63.379m USD | 12M Return: -22.1% | US7595301083 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 78.7M
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
RELX PLC is a London-headquartered information analytics company that provides data-driven decision tools to professional and business customers across North America, Europe, and other international markets. The company operates through four reporting segments: Risk, Scientific Technical & Medical, Legal, and Exhibitions, each focused on a distinct professional customer base such as insurers, scientists, healthcare providers, lawyers, and event organizers. Its business model centers on aggregating proprietary and third-party content and combining it with proprietary technology and algorithms to deliver subscription-based analytics and workflow tools.
Classified within the GICS Industrials sector under the Research & Consulting Services sub-industry, RELX is a large-cap issuer traded on the NYSE via an ADR under the ticker RELX, with an IPO dating to October 1994. The company traces its origins to 1903 and was formerly known as Reed Elsevier PLC before adopting its current name in July 2015.
- Exhibitions segment revenue rebounds as trade show attendance normalizes
- Risk segment subscription revenue grows on insurance analytics demand
- AI product launches at Lexis and Elsevier expand margins
- Sterling weakness lifts reported revenue from North American operations
| Net Income: 2.26b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.20 > 0.02 and ΔFCF/TA 0.63 > 1.0 |
| NWC/Revenue: -36.61% < 20% (prev -31.89%; Δ -4.72% < -1%) |
| CFO/TA 0.20 > 3% & CFO 2.97b > Net Income 2.26b |
| Net Debt (8.73b) to EBITDA (3.88b): 2.25 < 3 |
| Current Ratio: 0.45 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.79b) vs 12m ago -5.71% < -2% |
| Gross Margin: 63.92% > 18% (prev 65.48%; Δ -1.56% > 0.5%) |
| Asset Turnover: 66.47% > 50% (prev 66.55%; Δ -0.09% > 0%) |
| Interest Coverage Ratio: 16.58 > 6 (EBIT TTM 3.12b / Interest Expense TTM 188.3m) |
| DSRI: 1.06 (Receivables 2.33b/2.16b, Revenue 9.73b/9.53b) |
| GMI: 1.02 (GM 65.48% / 63.92%) |
| AQI: 0.99 (AQ_t 0.79 / AQ_t-1 0.80) |
| SGI: 1.02 (Revenue 9.73b / 9.53b) |
| TATA: -0.05 (NI 2.26b - CFO 2.97b) / TA 14.9b) |
| Beneish M = -2.95 (Cap -4..+1) = A |
As of August 28, 2026, the stock is trading at USD 36.30 with a total of 1,703,371 shares traded. Over the past week, the price has changed by +2.60%, over one month by +2.62%, over three months by +11.37% and over the past year by -22.08%.
Current recommended Stop Loss: 34.60 (which is 4.7% or 1.8 ATR below the current price).
Relx has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy RELX.
- StrongBuy: 1
- Buy: 0
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 53.1 | 46.1% |
Market Cap GBP = 46.6b (63.4b USD * 0.7354 USD.GBP)
P/E Trailing = 21.157
P/E Forward = 17.9533
P/S = 6.5205
P/B = 37.1702
P/EG = 1.3818
Revenue TTM = 9.73b GBP
EBIT TTM = 3.12b GBP
EBITDA TTM = 3.88b GBP
Long Term Debt = 5.63b GBP (from longTermDebt, last fiscal year)
Short Term Debt = 2.33b GBP (from shortTermDebt, last quarter)
Debt = 8.95b GBP (from shortLongTermDebtTotal, last quarter) + Leases 97.0m
Net Debt = 8.73b GBP (calculated: Debt 8.95b - CCE 218.7m)
Enterprise Value = 55.3b GBP (46.6b + Debt 8.95b - CCE 218.7m)
Interest Coverage Ratio = 16.58 (Ebit TTM 3.12b / Interest Expense TTM 188.3m)
EV/FCF = 18.76x (Enterprise Value 55.3b / FCF TTM 2.95b)
FCF Yield = 5.33% (FCF TTM 2.95b / Enterprise Value 55.3b)
FCF Margin = 30.33% (FCF TTM 2.95b / Revenue TTM 9.73b)
Net Margin = 23.28% (Net Income TTM 2.26b / Revenue TTM 9.73b)
Gross Margin = 63.92% ((Revenue TTM 9.73b - Cost of Revenue TTM 3.51b) / Revenue TTM)
Gross Margin QoQ = 64.09% (prev 63.75%)
Tobins Q-Ratio = 3.70 (Enterprise Value 55.3b / Total Assets 14.9b)
Interest Expense / Debt = 2.10% (Interest Expense 188.3m / Debt 8.95b)
Taxrate = 23.94% (716.3m / 2.99b)
NOPAT = 2.37b (EBIT 3.12b * (1 - 23.94%))
Current Ratio = 0.45 (Total Current Assets 2.90b / Total Current Liabilities 6.46b)
Debt / Equity = 7.27 (Debt 8.95b / totalStockholderEquity, last quarter 1.23b)
Debt / EBITDA = 2.25 (Net Debt 8.73b / EBITDA 3.88b)
Debt / FCF = 2.96 (Net Debt 8.73b / FCF TTM 2.95b)
Total Stockholder Equity = 2.31b (last 4 quarters mean from totalStockholderEquity)
RoA = 15.47% (Net Income 2.26b / Total Assets 14.9b)
RoE = 97.86% (Net Income TTM 2.26b / Total Stockholder Equity 2.31b)
RoCE = 39.31% (EBIT 3.12b / Capital Employed (Equity 2.31b + L.T.Debt 5.63b))
RoIC = 22.42% (NOPAT 2.37b / Invested Capital 10.6b)
WACC = 5.35% (E(46.6b)/V(55.6b) * Re(6.07%) + D(8.95b)/V(55.6b) * Rd(2.10%) * (1-Tc(0.24)))
Discount Rate = 6.07% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -95.28 | Cagr: -3.18%
[DCF] Terminal Value 76.40% ; FCFF base≈2.87b ; Y1≈3.06b ; Y5≈3.67b
[DCF] Fair Price = 27.35 (EV 56.4b - Net Debt 8.73b = Equity 47.6b / Shares 1.74b; r=8.35% [WACC [floored]]; 5y FCF grow 7.71% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.0 | # QB: 0
Revenue Correlation: 98.57 | Revenue CAGR: 2.26% | SUE: N/A | # QB: 0
EPS current Year (2026-12-31): EPS=1.92 | Chg30d=+1.03% | Revisions=+0% | GrowthEPS=+10.0% | GrowthRev=+5.1%
EPS next Year (2027-12-31): EPS=2.16 | Chg30d=+1.55% | Revisions=+0% | GrowthEPS=+12.7% | GrowthRev=+6.6%
[Analyst] Revisions Ratio: +0% (up=2, down=2)